AMBONI, Marianna
 Distribuzione geografica
Continente #
AS - Asia 11.538
NA - Nord America 5.732
EU - Europa 2.261
SA - Sud America 800
OC - Oceania 56
AF - Africa 53
Continente sconosciuto - Info sul continente non disponibili 5
Totale 20.445
Nazione #
HK - Hong Kong 9.004
US - Stati Uniti d'America 5.615
SG - Singapore 1.012
CN - Cina 686
BR - Brasile 670
IT - Italia 406
RU - Federazione Russa 397
UA - Ucraina 341
VN - Vietnam 313
DE - Germania 294
IE - Irlanda 217
TR - Turchia 185
SE - Svezia 154
KR - Corea 145
GB - Regno Unito 111
EE - Estonia 107
FI - Finlandia 73
CA - Canada 66
AR - Argentina 49
IN - India 45
FR - Francia 32
AU - Australia 30
BD - Bangladesh 30
EC - Ecuador 30
PL - Polonia 28
JP - Giappone 27
MX - Messico 25
NZ - Nuova Zelanda 24
ID - Indonesia 22
NL - Olanda 17
ZA - Sudafrica 17
CZ - Repubblica Ceca 16
ES - Italia 15
VE - Venezuela 12
IQ - Iraq 11
PY - Paraguay 11
AT - Austria 10
CO - Colombia 10
PK - Pakistan 10
IL - Israele 8
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
BE - Belgio 7
KE - Kenya 7
MA - Marocco 7
CL - Cile 6
PE - Perù 6
AL - Albania 5
EU - Europa 5
JM - Giamaica 5
LT - Lituania 5
NP - Nepal 5
DO - Repubblica Dominicana 4
EG - Egitto 4
ET - Etiopia 4
AZ - Azerbaigian 3
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
CH - Svizzera 3
DZ - Algeria 3
GT - Guatemala 3
HR - Croazia 3
ME - Montenegro 3
OM - Oman 3
TN - Tunisia 3
UY - Uruguay 3
BH - Bahrain 2
BO - Bolivia 2
BS - Bahamas 2
BW - Botswana 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
DK - Danimarca 2
IR - Iran 2
NI - Nicaragua 2
PA - Panama 2
PR - Porto Rico 2
RS - Serbia 2
SA - Arabia Saudita 2
TH - Thailandia 2
TJ - Tagikistan 2
CY - Cipro 1
DM - Dominica 1
GA - Gabon 1
GF - Guiana Francese 1
GP - Guadalupe 1
HN - Honduras 1
JO - Giordania 1
KY - Cayman, isole 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MN - Mongolia 1
MR - Mauritania 1
NC - Nuova Caledonia 1
RO - Romania 1
RW - Ruanda 1
SI - Slovenia 1
Totale 20.442
Città #
Hong Kong 8.992
Ann Arbor 1.105
Princeton 518
Chandler 509
Wilmington 468
Jacksonville 429
Dallas 403
Singapore 325
Ashburn 266
Houston 253
Dublin 204
Woodbridge 201
Izmir 166
Beijing 158
Dong Ket 136
Nanjing 112
Moscow 110
Tallinn 107
Andover 104
Boardman 86
Salerno 69
Munich 65
Pellezzano 64
Ho Chi Minh City 59
Los Angeles 56
São Paulo 56
Düsseldorf 55
Norwalk 53
Hanoi 45
Dearborn 44
Shenyang 43
Nanchang 39
Naples 36
Fairfield 34
Mestre 34
New York 31
Hebei 29
Redwood City 26
Rio de Janeiro 26
Jiaxing 25
San Francisco 24
Rome 21
Warsaw 21
Changsha 20
Montreal 20
The Dalles 20
Pune 18
Tianjin 18
Santa Clara 17
Milan 16
Nuremberg 16
San Diego 16
Washington 16
Brooklyn 15
Council Bluffs 15
Boston 14
Casoria 14
Guarulhos 14
Atlanta 13
Belo Horizonte 13
Chennai 13
Turku 13
Ankara 12
Brasília 12
Haiphong 12
London 12
Porto Alegre 12
Seoul 12
Stockholm 12
Tokyo 12
Amsterdam 11
Auckland 11
Guangzhou 11
Quito 11
Sydney 11
Columbus 10
Curitiba 10
Phoenix 10
Poplar 10
West Jordan 10
Campinas 9
Denver 9
Dhaka 9
Guayaquil 9
Cape Town 8
Ribeirão Preto 8
Salvador 8
Seattle 8
Cambridge 7
Carapicuíba 7
Chicago 7
Jinan 7
Manchester 7
Nairobi 7
Osasco 7
Santa Maria A Vico 7
Tashkent 7
Thái Bình 7
Wuhan 7
Anápolis 6
Totale 16.260
Nome #
Step length predicts executive dysfunction in Parkinson’s disease: a 3-year prospective study 962
Sex Differences in Parkinson’s Disease: From Bench to Bedside 625
Quantitative gait assessment in Parkinsonian patients with or without Mild Cognitive Impairment 582
Prevalence and associated features of self-reported freezing of gait in Parkinson disease: The DEEP FOG study 573
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease. 516
Gender differences in microRNA expression in levodopa-naive PD patients 515
Gait Analysis in Progressive Supranuclear Palsy Phenotypes. 489
Combined regional T1w/T2w ratio and voxel-based morphometry in multiple system atrophy: A follow-up study 478
Treatment of nocturnal disturbances and excessive daytime sleepiness in Parkinson's disease. 412
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 409
Fist-Palm Test May Identify Mild Cognitive Impairment and Freezing of Gait in Parkinson's Disease: A Machine Learning Approach 372
The most effective way to obtain long-term memory is to increase first presentation duration of single words 346
Resting-state brain connectivity in patients with Parkinson's disease and freezing of gait. 306
A longitudinal study of cognitive dysfunction in patients affected by Parkinson’s disease with and without freezing of gait 285
Effect of Global Postural Rehabilitation program on spatiotemporal gait parameters of parkinsonian patients: a three-dimensional motion analysis study. 259
Relationship Between Orthostatic Hypotension and Cognitive Functions in Multiple System Atrophy: A Longitudinal Study 258
Dual-task-related gait patterns as possible marker of precocious and subclinical cognitive alterations in Parkinson disease 257
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients. 243
Classifying Different Stages of Parkinson’s Disease Through Random Forests 235
Diagnostics and Ecological Validity of the Italian Version of the Parkinson's Disease Cognitive Rating Scale 222
Metabolomics in Parkinson's disease 220
Intraocular pressure and choroidal thickness postural changes in multiple system atrophy and Parkinson's disease 199
Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects 197
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study 186
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 182
Validation of the Italian version of carers’ quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy 175
Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkindisease 172
A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations. 163
Anxiety in early Parkinson's disease: Validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS) 161
Olfaction in Homozygous and Heterozygous SYNJ1 Arg258Gln Mutation Carriers 159
Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale 151
Measurements of Postural Sway to Classify Freezing of Gait in Parkinson's Disease 146
Machine learning can detect the presence of Mild cognitive impairment in patients affected by Parkinson’s Disease 142
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 138
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 135
A longitudinal study on the effects of COVID-19 pandemic on non-motor symptoms in Parkinson's disease 134
A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease 132
A two-year follow-up study of executive dysfunctions in parkinsonian patients with freezing of gait at on-state. 128
Increased bilirubin levels in de novo Parkinson's disease 124
A quantitative analysis of muscular co-activation on EMG signals in spastic patients treated with Botulinum toxin 124
Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study 124
An easy tool to improve accuracy in pre-diagnostic Parkinson's disease population 120
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease 118
Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients. 117
Serum uric acid is associated with apathy in early, drug-naïve Parkinson’s disease 116
Quitting smoking: An early non-motor feature of Parkinson's disease? 115
Clinical and neurological abnormalities in adult celiac disease. 114
Pisa syndrome in Parkinson's disease and parkinsonism: clinical features, pathophysiology, and treatment 112
Resting-state functional connectivity associated with mild cognitive impairment in Parkinson’s disease 110
Caffeine consumption and the 4-year progression of de novo Parkinson's disease 110
Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients? 109
Freezing of gait and executive functions in patients with Parkinson’s disease 109
Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease 107
Abnormal eating behaviors in progressive supranuclear palsy. 106
Bisphenol A glucuronidation in patients with Parkinson's disease 103
Assessment of apathy minimising the effect of motor dysfunctions in Parkinson’s disease: a validation study of the dimensional apathy scale 103
Biomechanics Parameters of Gait Analysis to Characterize Parkinson's Disease: A Scoping Review 102
Gender and non motor fluctuations in Parkinson's disease: A prospective study 102
Machine learning can predict mild cognitive impairment in Parkinson's disease 101
The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients. 98
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson’s disease 98
Classifying patients affected by Parkinson’s disease into freezers or non-freezers through machine learning 96
Short-latency afferent inhibition in patients with Parkinson’s disease and freezing of gait 93
The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy. 91
Regional Gray Matter Atrophy in Patients with Parkinson Disease and Freezing of Gait. 91
“Response to Apomorphine in early Parkinson’s disease”. 90
Cognitive correlates of “pure apathy” in Parkinson's disease 90
The non-motor side of the honeymoon period of Parkinson's disease and its relationship with quality of life: A 4-year longitudinal study 89
A metabolomic signature of treated and drug-naïve patients with Parkinson’s disease: a pilot study 89
Gait patterns in Parkinsonian patients with or without mild cognitive impairment. 88
Segmental progression of cardinal motor symptoms in Parkinson's disease: A pilot study suggesting a practical approach to rate disease course in the early stages. 88
Relationship between apathy and cognitive dysfunctions in de novo untreated Parkinson's disease: a prospective longitudinal study. 87
Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease 87
Presence and progression of non-motor symptoms in relation to uric acid inde novoParkinson's disease 86
Music Therapy for Motor and Nonmotor Symptoms of Parkinson's Disease: A Prospective, Randomized, Controlled, Single-Blinded Study 86
Resting-state brain networks in patients with Parkinson's disease and impulse control disorders 86
Uric acid relates to dopamine transporter availability in Parkinson's disease. 85
Cerebellar and pyramidal dysfunctions, palpebral ptosis and weakness aspresenting symptoms of PARK-2 85
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients 84
Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson's disease. 83
Apathy in Parkinson's disease: differences between caregiver's report and self-evaluation 83
Mutation in theSYNJ1Gene Associated with Autosomal Recessive, Early-Onset Parkinsonism 82
Parkinson’s disease and the spectrum of Lewy body disease 82
Comment on Szewczyk-Krolikowski et al.: The influence of age and gender on motor and non-motor features of early Parkinson's disease: Initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort 80
Multiple system atrophy is associated with changes in peripheral insulin-like growth factor system 79
Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease 77
Comparing PIGD and Akinetic-Rigid subtyping of Parkinson Disease and their stability over time 77
The Role of Deep Learning and Gait Analysis in Parkinson’s Disease: A Systematic Review 76
Resting brain networks in patients with Parkinson's disease and freezing of gait 76
Identification by [99mTc]ECD SPECT of anterior cingulate hypoperfusion in progressive supranuclear palsy, in comparison with Parkinson's disease 75
Ropinirole as a treatment of restless legs syndrome in patients on chronichemodialysis: an open randomized crossover trial versus levodopa sustainedrelease 74
Do Subjective Memory Complaints Herald the Onset of Mild Cognitive Impairment in Parkinson Disease? 74
Cognitive contributions to gait and falls: Evidence and implications 73
Vestibular impairment and adaptive postural imbalance in parkinsonian patients with lateral trunk flexion 73
Neuropsychological correlates of theory of mind in patients withearly Parkinson's disease. 72
Gender differences in non-motor symptoms in early Parkinson's disease: A 2-years follow-up study on previously untreated patients. 72
Caratteristiche Cliniche 72
Non-motor symptoms in early Parkinson's disease: a 2-year follow-up study on previously untreated patients. 71
Gait patterns and cognition in Parkinson's disease 71
The "eye of the tiger" sign in pure akinesia with gait freezing. 69
Totale 16.988
Categoria #
all - tutte 63.235
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.235


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021602 0 0 0 0 107 60 83 6 68 3 95 180
2021/2022829 9 2 12 14 6 1 7 33 112 117 120 396
2022/20231.274 154 67 37 114 203 295 11 111 185 12 61 24
2023/2024772 44 105 40 42 29 90 25 63 35 57 108 134
2024/20252.220 78 20 31 180 80 182 273 203 320 263 296 294
2025/202611.181 1.587 4.538 3.992 682 382 0 0 0 0 0 0 0
Totale 20.842